Technical Analysis for HLS - Hydralogic Systems Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical HLS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| Up 5 Days in a Row | Strength | 0.00% | |
| MACD Bullish Centerline Cross | Bullish | 1.66% | |
| MACD Bullish Signal Line Cross | Bullish | 1.66% | |
| Up 3 Days in a Row | Strength | 1.66% | |
| Up 4 Days in a Row | Strength | 1.66% | |
| Up 5 Days in a Row | Strength | 1.66% | |
| 20 DMA Support | Bullish | 3.32% | |
| Narrow Range Bar | Range Contraction | 3.32% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Rose Above Previous Day's High | about 9 hours ago | |
| Rose Above Previous Day's High | 3 days ago | |
| Rose Above 10 DMA | 3 days ago | |
| 200 DMA Resistance | 3 days ago | |
| 50 DMA Resistance | 3 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2020-11-05
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and Barbados. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.
Keywords: Marketing Specialty Pharma Pharmaceutical Life Sciences Pharmaceutical Products Psy Dermatology Nervous System Central Nervous System Schizophrenia
Classification
Keywords: Marketing Specialty Pharma Pharmaceutical Life Sciences Pharmaceutical Products Psy Dermatology Nervous System Central Nervous System Schizophrenia
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 23.5 |
| 52 Week Low | 13.35 |
| Average Volume | 43,354 |
| 200-Day Moving Average | 16.963 |
| 50-Day Moving Average | 17.030 |
| 20-Day Moving Average | 17.059 |
| 10-Day Moving Average | 16.924 |
| Average True Range | 0.563 |
| ADX | 15.29 |
| +DI | 27.906 |
| -DI | 16.192 |
| Chandelier Exit (Long, 3 ATRs ) | 16.312 |
| Chandelier Exit (Short, 3 ATRs ) | 17.938 |
| Upper Bollinger Band | 17.958 |
| Lower Bollinger Band | 16.160 |
| Percent B (%b) | 0.88 |
| BandWidth | 10.540 |
| MACD Line | 0.067 |
| MACD Signal Line | -0.006 |
| MACD Histogram | 0.0729 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.655 | ||||
| Resistance 3 (R3) | 18.607 | 18.253 | 18.503 | ||
| Resistance 2 (R2) | 18.253 | 18.020 | 18.278 | 18.452 | |
| Resistance 1 (R1) | 17.997 | 17.876 | 18.125 | 18.045 | 18.401 |
| Pivot Point | 17.643 | 17.643 | 17.708 | 17.668 | 17.643 |
| Support 1 (S1) | 17.387 | 17.410 | 17.515 | 17.435 | 17.079 |
| Support 2 (S2) | 17.033 | 17.266 | 17.058 | 17.028 | |
| Support 3 (S3) | 16.777 | 17.033 | 16.978 | ||
| Support 4 (S4) | 16.825 |
